Item

Correction to: The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe

Ruiz-Casas, Leonardo
; 
Evans, Jonathan
; 
Rose, Alison
; 
Pedra, Gabriel Ghizzi
; 
Lobo, Alan
; 
Finnegan, Alan
; 
Hayee, Bu
; 
Peyrin-Biroulet, Laurent
; 
Sturm, Andreas
; 
Burisch, Johan
... show 5 more
Citations
Altmetric:
Advisors
Editors
Other Contributors
Affiliation
HCD Economics; Sheffield Teaching Hospitals NHS Foundation Trust; University of Sheffield; University of Chester; King’s College Hospital NHS Foundation Trust, London; University Hospital Centre Nancy; DRK Kliniken Berlin; Hvidovre Hospital; Crohn’s and Colitis UK; European Federation of Crohn’s and Ulcerative Colitis Associations; IBDrelief; Istituto Clinico Humanitas; Pennine Acute Hospitals NHS Trust
EPub Date
Publication Date
2021-12-15
Submitted Date
Collections
Health and Social Care
Show all metadata
Other Titles
Abstract
After publication of this article [1], the authors reported that the author name “Avedano” was incorrectly written as “Avendano”. The original article [1] has been updated.
Citation
Ruiz-Casas, L., Evans, J., Rose, A., Pedra, G. G., Lobo, A., Finnegan, A., Hayee, B., Peyrin-Biroulet, L., Sturm, A., Burisch, J., Terry, H., Avedano, L., Tucknott, S., Fiorino, G., & Limdi, J. (2021). Correction to: The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe. BMC Gastroenterology, 21, article-number 475. https://doi.org/10.1186/s12876-021-02062-3
Publisher
BioMed Central
Journal
BMC Gastroenterology
Research Unit
URI
http://hdl.handle.net/10034/629765
DOI
10.1186/s12876-021-02062-3
PubMed ID
PubMed Central ID
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
1471-230X
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
This work was supported by Eli Lilly and Pfizer internationally, and by Celgene in the UK.
Additional Links
https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-021-02062-3
Embedded videos